Olema Total Stockholder Equity from 2010 to 2025
| OLMA Stock | USD 4.11 0.09 2.14% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 409 M | Current Value 230.4 M | Quarterly Volatility 152.8 M |
Check Olema Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Olema Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 13.3 M, Interest Income of 13.3 M or Depreciation And Amortization of 445.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.88. Olema financial statements analysis is a perfect complement when working with Olema Pharmaceuticals Valuation or Volatility modules.
Olema | Total Stockholder Equity |
Latest Olema Pharmaceuticals' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Olema Pharmaceuticals over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Olema Pharmaceuticals' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Olema Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Olema Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 102,901,499 | |
| Geometric Mean | 26,850,503 | |
| Coefficient Of Variation | 148.49 | |
| Mean Deviation | 137,013,874 | |
| Median | (6,278,000) | |
| Standard Deviation | 152,794,099 | |
| Sample Variance | 23346T | |
| Range | 419.6M | |
| R-Value | 0.80 | |
| Mean Square Error | 9130.9T | |
| R-Squared | 0.63 | |
| Significance | 0.0002 | |
| Slope | 25,573,273 | |
| Total Sum of Squares | 350190.5T |
Olema Total Stockholder Equity History
About Olema Pharmaceuticals Financial Statements
Olema Pharmaceuticals stakeholders use historical fundamental indicators, such as Olema Pharmaceuticals' Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Olema Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Olema Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Olema Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Olema Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 409 M | 230.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Olema Pharmaceuticals Correlation against competitors. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. If investors know Olema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Olema Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Olema Pharmaceuticals is measured differently than its book value, which is the value of Olema that is recorded on the company's balance sheet. Investors also form their own opinion of Olema Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Olema Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Olema Pharmaceuticals' market value can be influenced by many factors that don't directly affect Olema Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Olema Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Olema Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.